MohamadAliCherryMD

PubMed

• 1 citations
  OUTREACH: phase 2 study of lisocabtagene maraleucel as outpatient or inpatient treatment at community sites for R/R LBCL.
  Yuliya Linhares, Cesar O Freytes, Mohamad Cherry, Carlos Bachier, Michael Maris
  Blood Advances. 2024-12-10
• 14 citations
  Gilteritinib in Combination With Induction and Consolidation Chemotherapy and as Maintenance Therapy: A Phase IB Study in Patients With Newly Diagnosed AML.
  Keith W Pratz, Mohamad Cherry, Jessica K Altman, Brenda W Cooper, Nikolai A Podoltsev
  Journal of Clinical Oncology. 2023-09-10
• 3 citations
  Gray zone lymphoma: A case report and comprehensive review of literature.
  Dariusz Uczkowski, Hamza Ashraf, Mohamad Cherry, Nikolay Dimov
  Leukemia Research Reports. 2023-01-01

Journal Articles

• Secondary solid tumors and lymphoma in patients with essential thrombocythemia and polycythemia vera-single center experience  
  Masarova L, Cherry M, Newberry KJ Estrov Z, Cortes JE, Kantarjian HM, Verstovsek S, Leuk Lymphoma, 1/22/2015
• Prospective evaluation of protein C and factor VIII in prediction of cancer-associated thrombosis  
  Tafur AJ, Dale G, Cherry M, Wren JD, Mansfield AS, Comp P, Rathbun S, Stoner JA, Thromb Res, 1/1/2015
• Erlotinib is not effective in patients with JAK2V617F-positive polycythemia vera  
  Cherry M, Khawandanah M, Zhao ZJ, Srour S, Ozer H, Selby G, Ghabache B, Al-Kali A, Ann Hematol, 1/9/2014
• Central venous catheter-related complications in acute myeloid leukemia patients  
  Khalil MO, Pierson N, Maymani H, Holter J, Cherry M, J Vasc Access, 1/5/2014
• Antitumor activity of an enzyme prodrug therapy targeted to the breast tumor vasculature  
  Van Rite BD, Krais JJ, Cherry M, Sikavitsas VI, Kurkjian C, Harrison RG, Cancer Invest, 1/1/2013
• Patients with polycythemia vera and essential thrombocythemia with prior malignancy do not have significantly worse outcome  
  Cherry M, Cardenas-Turanzas M, Pham H, Kantarjian H, Cortes J, Pierce S, Zhou L, Verstovsek S, Leuk Res, 1/1/2013
• Bone Marrow Fibrosis Reversal After Use of Hydroxyurea in a Patient with Myelofibrosis  
  Cherry M, Srour S, Kern W, Al-Kali A, Community Oncology, 1/1/2013
• Ifosfamide Induced Neurotoxicity Reversal With Continuous Veno-Venous Hemodialysis A Case Report  
  Mohamad Cherry, Himanshu Bhardwaj, Sarah Hopps, Samer Srour, Shubham Pant, J Oncol Pharm Pract, 1/7/2012
• The Role of Monoclonal Antibodies in the Management of Leukemia  
  Ali Al-Ameri, Mohamad Cherry, Aref Al-Kali1 and Alessandra Ferrajoli, Pharmaceuticals, 1/1/2010
• An AML Case Initially Treated as CLL: What Do We Know about t(4,12)(q12;p13)?  
  Aref Al-Kali, Mohamad Cherry, Kimmell K, Jennifer Holter, William Kern, Bradly Gehrs, Howard Ozer , George Selby, Cancer Genet Cytogenet, 1/1/2010
• Efficacy of BACTEC vs Conventional Culture in Laboratory Diagnosis of Mycobacterial Infections: the AUBMC Experience  
  Mohamad Cherry, Georges Araj, et al, J Med Liban, 1/1/2005
• Join now to see all

Books/Book Chapters

• Chronic Myeloid Leukemia: From Daily Management to Complicated Issues 
  Chapter: Management of Chronic Myeloid Leukemia (CML): Accelerated Phase (AP) 
  Page 157 - 166Mohamad Cherry and Aref Al KaliEditors: Celalettin Ustun and Uday R. Popat.Nova Science Publishers, New YorkEdition 1st,2013
• Perry's The Chemotherapy Source Book 
  Chapter: Biologic Response Modifiers: Principles of Biotherapy. 
  Page 64 - 79Cherry M, Ozer HLippincott Williams & Wilkins, PhiladelphiaEdition 5th,2012

Abstracts/Posters

• Using in-vitro and in-vivo studies to personalize therapy for AML.
  Suraj Pratap, Wanke Zhao, Richard A. Allen, Mohamad Cherry, Joe Z. Zhao, American Society of Pediatric Hematology & Oncology (ASPHO) Annual Meeting, 1/1/2017
• Extra-nodal marginal zone lymphoma (malt lymphoma) in the central Nervous system presenting as a meningioma.
  Adanma Ayanambakkam, MD, Alekhya Mitta, MBBS Khalid Bilal, MD & Mohamed Cherry, MD, Oklahoma ACP Chapter Meeting, 1/1/2016
• Analysis of Outcome of Patients with Acute Myeloid Leukemia According to Socio-Economic Status.
  Namali Pierson, Shawn Chaudry, Gabriel Vidal, Michael Machiorlatti, Summer Frank, Sara K. Vesely, James K. Feisal, Samer A Srour, Mohammad O. Khalil, Alexandra Ikeguch..., Blood, 1/4/2015
• Prognostic Significance of Weight Loss and BMI during Induction Chemotherapy of Newly Diagnosed Acute Myeloid Leukemia (AML) Patients
  Zachary Smith, Gabriel Vidal, Michael Machiorlatti, Sara K. Vesely, Summer Frank, Adam S. Asch, Jennifer L Holter-Chakrabarty, Mohamad Khawandanah, Mohamad Cherry, Blood, 1/4/2015
• Further Evidence to Not Delay Transplant for Continued ARA-C Consolidation in Patients with Intermediate or High Risk AML.
  James K. Feisal, Nicholas B. Pleat, Michael Machiorlatti, Summer Frank, Sara Vesley, Sarah Schmidt, George Selby, Carrie Yuen, Jennifer L Holter-Chakrabarty, Mohamad C..., Blood, 1/4/2015
• Combination Trial of Duvelisib (IPI-145) with Bendamustine, Rituximab, or Bendamustine/Rituximab in Patients with Lymphoma or Chronic Lymphocytic Leukemia.
  Ian W. Flinn, Mohamad Cherry, Michael Maris, Jeffrey V. Matous, Jesus G. Berdeja, Manish R. Patel, Blood, ASH (American Society of Hematology), 1/1/2015
• Western Intravascular Lymphoma (IVL): Case Series of Published Reports Between 1994-2014.
  Mohamad Khawandanah, Bilal Ahmad, Fahad Khan, Jennifer L. Holter Chakrabarty, Carrie Yuen, George Selby, Adam S. Asch, Mohamad Cherry, Blood, 1/5/2014
• An Open-Label, Phase Ib Study of Duvelisib (IPI-145) in Combination with Bendamustine, Rituximab or Bendamustine/Rituximab in Select Subjects with Lymphoma or Chronic ...
  Ian Flinn, Manish R. Patel, Michael B Maris, Jeffrey Matous, Mohamad Cherry and Jesus G. Berdeja, ASH (American Society of Hematology), 1/1/2014
• Time from Hospital Admission to Induction Chemotherapy Adversely Affects Outcomes in Patients with Acute Myeloid Leukemia.
  Hossein Maymani, Bilal Ahmad, Michael G Machiorlatti, Sara K. Vesely, Samer A Srour, George Selby, Adam S. Asch, and Mohamad Cherry, MD, ASH (American Society of Hematology), 1/1/2014
• Impact of Insurance Status on the Day of Admission and Clinical Outcome on Acute Myeloid Leukemia (AML) Patients.
  Bilal Ahmad, Hossein Maymani, Haseeb Saeed, Mohamad Khawandanah, Samer A Srour, Michael G Machiorlatti, Adam S. Asch, and Mohamad Cherry, ASH (American Society of Hematology), 1/1/2014
• Mediastinal Germ Cell Tumor and Acute Megakaryoblastic Leukemia-a Systematic Review of Cases Reported in the Literature.
  Sonia John, Mohammed Abdul Muqeet Adnan, Mohammad O. Khalil, George Selby, Adam S. Asch, Mohamad Cherry, and Mohamad Khawandanah, ASH (American Society of Hematology), 1/1/2014
• Acute Myeloid Leukemia: Pretreatment Biochemical and Clinical Variables Predictive For Risk Status Based On Validated Cytogenetic and Molecular Abnormalities.
  Samer A Srour, Michael G Machiorlatti, Mohamad Cherry, Namali Pierson, Usman Z Bhutta, David M Thompson, Carla D Kurkjian, Blood, 1/6/2013
• Analysis Of Impact Of Distance From Residence To Treatment Center On The Outcome Of Patients With Acute Myeloid Leukemia.
  David W. Lam, MD, Hossein Maymani, MD, Michael G Machiorlatti, MS, Samer A Srour, MB ChB, Minh Phan, MD, George Selby, MD, Jennifer L. Holter, MD and Mohamad Cherry, MD, ASH (American Society of Hematology), 1/1/2013
• Erlotinib Is Not Effective In Patients (Pts) With JAK-2 V617F Positive Polycythemia Vera.
  Mohamad Cherry, MD, Mohamad Khawandanah, MD, Zhizhuang Joe Zhao, Samer Srour, MB ChB, Howard Ozer, MD, PhD, George Selby, MD, Bassam Ghabache, MD and Aref Al-Kali, MD, ASH (American Society of Hematology), 1/1/2013
• Predictors of cancer associated thrombosis.
  Alfonso Tafur, MD, George L. Dale, PhD, Suman Rathbun, MD, Aaron S. Mansfield, MD, Mohamad Cherry, MD, Philip C. Comp, MD, PhD, Jonathan Wren, PhD, and Julie Stoner, PhD, ASH (American Society of Hematology), 1/1/2013
• Catheter-Related Complications in Acute Myeloid Leukemia Patients After Hematopoietic Stem Cell Transplant.
  Mohammad O. Khalil, Namali Pierson, George Selby, Mohamad Cherry, Jennifer Holter, Biology of Blood and Marrow Transplantation, 1/1/2013
• Patients with FLT3 Negative Acute Myeloid Leukemia and Normal Cytogenetic who Have the Combination Mutations (NPM1-/CEBPA-) Have Better Survival Than Patients Who Have...
  Shamail Butt, Pascal Akl, Himanshu Bhardwaj, Samer A Srour, Terry Dunn, Shubham Pant, and Mohamad Ali Cherry, ACR (American College of Rheumatology) Meeting, 1/1/2013
• Acute myeloid leukemia: Comparison of epidemiology and treatment outcomes between insured and uninsured patients.
  Samer Ali Srour, Michael Machiorlatti, Usman Bhutta, Namali Pierson, Mohamad Ali Cherry, Shubham Pant, David Thompson, Carla Kurkjian, J Clin Oncol, 1/1/2012
• Comparison of Complications Related to Peripherally Inserted Central Catheters, Infusion Ports, and Hickman Catheters in Acute Myeloid Leukemia Patients
  Mohammad O. Khalil, MD, Namali Pierson, MD, Hossein Maymani, MD, Jennifer L. Holter, MD and Mohamad Ali Cherry, MD, ASH (American Society of Hematology), 1/1/2012
• Secondary malignancies in essential thrombocythemia and polycythemia vera: A retrospective analysis of 437 patients from a single institution.
  M. A. Cherry, H. Pham, H. Kantarjian, A. Al-Ameri, J. E. Cortes, L. Zhou and S. Verstovsek, ASCO (American Society of Clinical Oncology), 1/9/2011
• Role of topotecan, vinorelbine, thiotepa, and gemcitabine (TVTG) chemotherapy in relapsed/refractory adult acute leukemia: A single-institution retrospective analysis.
  . A. Srour, M. A. Cherry, E. Borders, H. Parekh, J. L. Holter, T. S. Herman and G. B. Selby, ASCO (American Society of Clinical Oncology), 1/9/2011
• "The Role Of Complement System In The Pathogenesis Of Graft Versus Host Disease"
  Mohamad A Cherry, MD, Hiral Parekh, MD, Megan Lerner, HT, Zhongxin Yu, MD, George Selby, MD, Jennifer Holter, MD, ASBMT (American Society for Blood and Marrow Transplantation), 1/1/2011
• "Successful Autologous Stem Cell Transplant after 21 years of Cryopreservation."
  Mohamad Cherry, William Kern, Benjamin Wagenman, Kris Kratochvil, Robert Epstein, George Selby, Jennifer Holter, ASBMT (American Society for Blood and Marrow Transplantation), 1/1/2011
• Risk of progression to myelofibrosis and acute myeloid leukemia in patients with essential thrombocythemia and polycythemia vera with prior malignancy.
  M. A. Cherry, H. Pham, H. Kantarjian, J. E. Cortes, S. Pierce, L. Zhou, S. Verstovsek., J Clin Oncol, 1/1/2011
• "Efficacy Of Rasburicase In Acute Renal Failure In Patients With Tumor Lysis Syndrome"
  Mohamad Cherry, Samer Srour, Mohamad Khawandanah, Osama Qubaiah, Bassam Ghabach, ASH (American Society of Hematology), 1/1/2010
• Join now to see all

Lectures

• Descriptive Study of Genome-Wide DNA Methylation Patterns in Osteosarcoma Tissues and Their Potential Role as Predictive Biomarkers for Chemotherapy Response. 
  Oklahoma City - 1/1/2015
• "Acute Leukemia" 
  University of Oklahoma Health Sciences Center - 1/1/2015
• "Leukemia & Lymphoma" 
  University of Oklahoma Health Sciences Center, 2013, 2015 - 1/1/2015
• "The Role of PI3K Inhibitors in Lymphoid Malignancies" 
  1/27/2014
• "Lymphoproliferative Disorders Including NHL" 
  University of Oklahoma Health Sciences Center - 1/3/2014
• "The Charm of Targeted Therapy: An Introduction to Personalized Medicine in Oncology." 
  University of Oklahoma Health Sciences Center - 1/31/2013
• "The Charm of Targeted Therapy: An Introduction to Personalized Medicine in Oncology" 
  1/31/2013
• "Intro to Acute Leukemia" 
  University of Oklahoma Health Sciences Center - 1/19/2013
• "Sleep Deprivation." 
  University of Oklahoma Health Sciences Center - 1/7/2013
• "CML" 
  University of Oklahoma Health Sciences Center - 1/4/2013
• "AML-update regarding current management." 
  Witchita, KS - 1/3/2013
• Outcome Of Acute Myeloid Leukemia Patients According To Cytogenetic And Molecular Characteristics. 
  1/1/2013
• Analysis Of Impact Of Distance From Residence To Treatment Center On The Outcome Of Patients With Acute Myeloid Leukemia. 
  1/1/2013
• "Bone Marrow Failure Syndromes" 
  Beirut, Lebanon - 1/31/2012
• "Diffuse Large B Cell Lymphoma" 
  University of Oklahoma Health Sciences Center - 1/19/2012
• Treatment Tests of Breast Cancer in Mice Using a Vascular-Targeted Enzyme Prodrug Therapy. 
  1/1/2012
• "AML II-Treatment" 
  University of Oklahoma Health Sciences Center - 1/30/2011
• Join now to see all